This protocol is judged by an institutional overview board, an impartial group that reviews any medical trials involving individuals. If a review entails a Timetable I drug, as soon as the board approves the protocol as moral, the scientists need to make an application for an investigational new drug (IND) selection from your FDA.The good news is,